1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow MP0250 plus BOR+DEX: new trials by email Literature Review of MP0250 plus BOR+DEX trials Research Report on MP0250 plus BOR+DEX
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Trial of MP0250 Plus Bortezomib + Dexamethasone in Patients With Multiple Myeloma MP0250 plus BOR+DEX - Multiple Myeloma in Relapse | Phase 1 / Phase 2 | Completed | Molecular Partners AG | 33 | 2017-05-23 | 2021-08-25 |
Austria (1) · Czechia (1) · Denmark (1) · Germany (1) · Italy (1) · Poland (1)
2016 (1)